Cargando…

Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma

BACKGROUND: Constitutive MET signaling promotes invasiveness in most primary and recurrent GBM. However, deployment of available MET-targeting agents is confounded by lack of effective biomarkers for selecting suitable patients for treatment. Because endogenous HGF overexpression often causes autocr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Jennifer, Ascierto, Maria Libera, Mittal, Sandeep, Newsome, David, Kang, Liang, Briggs, Michael, Tanner, Kirk, Marincola, Francesco M., Berens, Michael E., Vande Woude, George F., Xie, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574608/ https://www.ncbi.nlm.nih.gov/pubmed/26381735 http://dx.doi.org/10.1186/s12967-015-0667-x

Ejemplares similares

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
por: Gowda, Madhu, et al.
Publicado: (2011)

Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy
por: Xie, Qian, et al.
Publicado: (2013)

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
por: Kou, Jianqun, et al.
Publicado: (2018)

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
por: Ascierto, Maria Libera, et al.
Publicado: (2013)

CLRM-01. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST)
por: Peng, Sen, et al.
Publicado: (2021)

Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles
por: Graveel, Carrie R., et al.
Publicado: (2010)

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
por: Smyth, Elizabeth C, et al.
Publicado: (2014)

Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Combination therapy: the next opportunity and challenge of medicine
por: Ascierto, Paolo A, et al.
Publicado: (2011)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
por: Qin, Anna, et al.
Publicado: (2023)

MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection
por: Sakamoto, Naoko, et al.
Publicado: (2017)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
por: Alvarez-Perez, Juan Carlos, et al.
Publicado: (2014)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
por: Taniguchi, Hirokazu, et al.
Publicado: (2017)

Met Kinetic Signature Derived from the Response to HGF/SF in a Cellular Model Predicts Breast Cancer Patient Survival
por: Stein, Gideon Y., et al.
Publicado: (2012)

Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells
por: Tate, Amanda, et al.
Publicado: (2006)

Antitumor Activity of Curcumin in Glioblastoma
por: Walker, Blake C., et al.
Publicado: (2020)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
por: Myint, Melissa, et al.
Publicado: (2023)

Review of non-SUSY scenarios with MET signatures
por: Gripaios, Ben Matthew
Publicado: (2011)

Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma
por: Yu, Guoyong, et al.
Publicado: (2019)

Evidence of a DHA Signature in the Lipidome and Metabolome of Human Hepatocytes
por: Ghini, Veronica, et al.
Publicado: (2017)

Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros
Publicado: (1995)

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
por: Parikh, Rahul A, et al.
Publicado: (2014)

Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016)

Editorial of Special Issue “New Aspects of the Hepatocyte Growth Factor/c-Met System”
por: Ricci, Giulia
Publicado: (2015)

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
por: Rothenberger, Natalie J., et al.
Publicado: (2017)

The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
por: Carvalho, Bruno, et al.
Publicado: (2021)

Circular RNA encoded MET variant promotes glioblastoma tumorigenesis
por: Zhong, Jian, et al.
Publicado: (2023)

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme
por: Chen, Bao-Shi, et al.
Publicado: (2020)

Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV
por: Marras, Francesco, et al.
Publicado: (2014)

Search for Dark Matter in X+MET signatures at the LHC
por: Frost, James
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j4v7qbtac1tqtg4fs4obum87he